| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 201 | 29 | 21 | 70 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 201 | 29 | 21 | 70 | | | Operating Expenses | | Research Development | 5,256 | 5,297 | 4,266 | 5,865 | | Selling General and Administrative | 3,207 | 2,562 | 2,892 | 3,415 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,262) | (7,830) | (7,137) | (9,210) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (32) | (383) | (775) | (974) | | Earnings Before Interest And Taxes | (8,294) | (8,213) | (7,912) | (10,184) | | Interest Expense | (764) | 327 | 437 | 391 | | Income Before Tax | (7,530) | (8,540) | (8,349) | (10,575) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,530) | (8,540) | (8,349) | (10,575) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (505) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,530) | (8,540) | (8,349) | (11,080) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,530) | ($8,540) | ($8,349) | ($11,080) |
|
0.51% Nasdaq 
Income Statement
